Team, Inc. Announces Changes to Its Board of Directors

(NYSE:TISI), SUGAR LAND, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced the following changes to the Board of Directors of the […]

Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications

The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9 in vivo using Amphista's proprietary, next generation Targeted Glue(TM) medicinal chemistry technology Amphista's scientists prospectively and rationally designed therapeutic molecules with a novel mechanism, intrinsic oral bioavailability and favourable drug-like properties Amphista's proprietary Targeted Glues(TM) offer an exciting new strategy for targeted protein

KE Holdings Inc. Upgraded to “AA” in MSCI ESG Rating

KE Holdings Inc. Upgraded to “AA” in MSCI ESG Rating GlobeNewswire October 27, 2025 BEIJING, Oct. 27, 2025 (GLOBE NEWSWIRE) — KE Holdings Inc. (“Beike” or the “Company“) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, is pleased to announce today a significant upgrade in its

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket’s Acquisition of Mr. Cooper in October 2025 to Contact the Firm

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket's Acquisition of Mr. Cooper in October 2025 to Contact the Firm GlobeNewswire October 27, 2025 SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) — Girard Sharp LLP, a national

Cenovus announces amendment to agreement with MEG Energy and voting support agreement with Strathcona Resources Ltd.

Cenovus announces amendment to agreement with MEG Energy and voting support agreement with Strathcona Resources Ltd. GlobeNewswire October 27, 2025 CALGARY, Alberta, Oct. 27, 2025 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that it has entered into a second amending agreement in respect of the arrangement agreement dated August 21,

Red Cat Successfully Completes Flight Testing of Palantir’s VNav Software on Black Widow(TM) Drone

Red Cat Successfully Completes Flight Testing of Palantir's VNav Software on Black Widow(TM) Drone Validation marks first known demonstration of visual navigation software on a U.S. Army program of record drone GlobeNewswire October 27, 2025 SAN JUAN, Puerto Rico, Oct. 27, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat'' or the

G2 Goldfields Issues Corporate & Exploration Update

G2 Goldfields Issues Corporate & Exploration Update GlobeNewswire October 27, 2025 Highlights of the maiden Preliminary Economic Assessment based on new updated gold mineral resource to be released in November Anticipated completion of G3 Spin-Out in December Drilling underway with several rigs testing multiple new high priority targets Visible gold identified within two of five

Team, Inc. Announces Changes to Its Board of Directors

Team, Inc. Announces Changes to Its Board of Directors GlobeNewswire October 27, 2025 SUGAR LAND, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services,

Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications

Amphista Therapeutics' successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications GlobeNewswire October 27, 2025 The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9 in vivo using Amphista's proprietary, next generation Targeted Glue(TM) medicinal chemistry technology Amphista's scientists prospectively and rationally

RAGNAROK 3 (Chinese Title: 仙境传说3) Received an ISBN Code by Chinese Government

RAGNAROK 3 (Chinese Title: 仙境传说3) Received an ISBN Code by Chinese Government GlobeNewswire October 27, 2025 Seoul, South Korea, Oct. 27, 2025 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that RAGNAROK 3 (Chinese Title: 仙境传说3), an MMORPG Mobile and PC game,

Scroll to Top